Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024: Market to Reach $2.14 Billion by 2028 - Long-term Forecasts to 2033


Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

The market, which stood at $1.58 billion in 2023, is expected to witness a steady growth, reaching a valuation of $1.69 billion in 2024, with a compound annual growth rate (CAGR) of 7.0%. This robust growth trajectory is anticipated to continue, with projections estimating the market to grow to $2.14 billion by 2028 at a CAGR of 6.1%.

Global demand for minimally invasive treatment options and increasing health care awareness among men are projected to drive growth in the benign prostatic hyperplasia (BPH) treatment devices and equipment market. Providing an in-depth analysis of current and future market scenarios, a new expert-industry research report has been added to our website, offering a comprehensive overview of the BPH treatment devices and equipment market.

Expanding Markets in Emerging Economies Drive Growth

The expanding markets in emerging economies and the increasing adoption of minimally invasive techniques are key factors propelling the market forward. As the aging population grows, so does the prevalence of prostate gland enlargement, creating a spike in demand for BPH treatment devices and equipment. In response to this, major industry stakeholders are focusing on innovation and development of new, less invasive treatment methods.

Trends Shaping the BPH Treatment Devices and Equipment Market

  • Non-surgical and office-based procedures are becoming more prominent as they offer convenience and reduce the need for hospital stays.
  • Laser and radiofrequency technologies are at the forefront of advancements in the treatment of BPH, promising greater precision and improved outcomes.
  • The integration of telemedicine and remote consultations is helping to expand access to specialist advice and ongoing management of BPH symptoms.
  • There is an increased emphasis on patient education and engagement, ensuring that patients are fully informed about their condition and the treatment options available.

Recent Innovations and Strategic Acquisitions

Industry leaders are making substantial investments in technologically advanced solutions such as Prostatic Artery Embolization (PAE) - a minimally invasive procedure that leverages imaging technologies to alleviate urinary tract symptoms related to BPH.

Recent product launches aim to address lower urinary tract symptoms more effectively while reducing complications associated with traditional surgical options. Strategic acquisitions have strengthened the position of key players in the market, enabling them to offer a broader range of non-surgical treatment options that improve the quality of life for men with BPH.

Regional Market Insights and Forecast

North America led the BPH treatment devices and equipment market in 2023, with Western Europe following closely behind. The global market research report covers detailed segments, market trends, and potential opportunities within the regions of Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

A selection of companies mentioned in this report includes

  • Karl Storz
  • Lumenis Ltd.
  • Olympus Corporation
  • Urologix LLC
  • Boston scientific Inc.
  • Endo International plc
  • NeoTract Inc.
  • OmniGuide Inc.
  • Medifocus Inc.
  • ProArc Medical Ltd.
  • Teleflex Incorporated
  • Medtronic plc
  • Urotech Devices
  • Prostalund Operations AB
  • Baxter International
  • NxThera Inc.
  • Richard Wolf GmbH
  • Coloplast A/S
  • Siemens Healthineers
  • Quest Pharmatech
  • Protox Therapeutics
  • IntelGenx Technologies Corp
  • Astellas Pharma Inc.
  • Ipsen S.A.
  • Biolitec AG
  • BVM Medical
  • Convergent Laser Technologies
  • Cook Medical
  • GreenLight Technologies
  • Merit Medical Systems
  • Pnn Medical A/S
  • PROCEPT BioRobotics
  • Prosenex
  • ProSolv CardioVascular Inc.
  • Quanta System
  • Rocamed SAM
  • RZ Medizintechnik GmbH
  • SRS Medical Systems
  • UroShape LLC
  • Vertebron Inc.

For more information about this report visit https://www.researchandmarkets.com/r/a9s93i

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data